LORI TSCHETTER: Open Payments
NPI 1689782740 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,400 in 170 payments from 25 companies in 2025. Trend: 2023 $1,951 · 2024 $1,896 · 2025 $2,400
Food & beverage: $2,400
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 50 | $295 |
| ABBVIE INC. | 14 | $268 |
| Novo Nordisk Inc | 12 | $262 |
| PFIZER INC. | 19 | $241 |
| Corcept Therapeutics | 23 | $231 |
| AstraZeneca Pharmaceuticals LP | 6 | $168 |
| Otsuka America Pharmaceutical, Inc. | 9 | $150 |
| Exact Sciences Corporation | 4 | $92 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $86 |
| Sumitomo Pharma America, Inc. | 4 | $80 |
Products named: ZORYVE, Korlym, REXULTI, Ozempic, UBRELVY, VRAYLAR, Cologuard Collection Kit, NURTEC ODT.
Industry payments across WA — which companies pay providers there.
